Astellas gets FDA approval for Vyloy plus chemo to treat gut cancers
Vyloy is a cytolytic monoclonal antibody (mAb) therapy, together with chemotherapy, indicated for adults with locally advanced HER2-negative gastric or GEJ adenocarcinoma whose tumours are CLDN 18.2-positive